| pubmed-article:6204182 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C1518997 | lld:lifeskim |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C0014242 | lld:lifeskim |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C2709199 | lld:lifeskim |
| pubmed-article:6204182 | lifeskim:mentions | umls-concept:C1752435 | lld:lifeskim |
| pubmed-article:6204182 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:6204182 | pubmed:dateCreated | 1984-8-14 | lld:pubmed |
| pubmed-article:6204182 | pubmed:abstractText | Opioid peptides are present in peripheral blood, and may bind to human lymphocytes. In order to determine their influence on human lymphocytes we studied the effect of endogenous opioid peptides on human lymphocyte natural killer function. Beta-endorphin and several analogues (i.e., gamma-endorphin) are shown to enhance human peripheral blood natural killer function. The enhancement of natural killing by these opioid peptides was dose-dependent and naloxone (an opiate antagonist) reversible. In studying various analogues of beta-endorphin, beta-lipotropin and gamma-endorphin were approximately 3-5 times more effective at enhancing peripheral blood NK function than Leu-enkephalin and -endorphin. In addition, we observed that naloxone reversed human fibroblast interferon mediated enhancement of human blood lymphocyte natural killer function. These observations suggest that circulating endogenous opioid peptides may have a physiologic role in regulating human blood lymphocyte natural killing. | lld:pubmed |
| pubmed-article:6204182 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6204182 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6204182 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6204182 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:6204182 | pubmed:issn | 0024-3205 | lld:pubmed |
| pubmed-article:6204182 | pubmed:author | pubmed-author:AllenJJ | lld:pubmed |
| pubmed-article:6204182 | pubmed:author | pubmed-author:MorleyJ EJE | lld:pubmed |
| pubmed-article:6204182 | pubmed:author | pubmed-author:KayNN | lld:pubmed |
| pubmed-article:6204182 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6204182 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:6204182 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:6204182 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6204182 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6204182 | pubmed:pagination | 53-9 | lld:pubmed |
| pubmed-article:6204182 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:meshHeading | pubmed-meshheading:6204182-... | lld:pubmed |
| pubmed-article:6204182 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6204182 | pubmed:articleTitle | Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. | lld:pubmed |
| pubmed-article:6204182 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6204182 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6204182 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6204182 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6204182 | lld:pubmed |
